Stratus Building Solutions

Hammer Packaging is a multicolor packaging printer of sheet-fed cut and stack labels, box wraps and premium packets, along with roll fed and water-base, flexo-graphic pressure sensitive labels, wrap labels and form and fill labels for consumer products. Some of the services offered by Hammer are remote proofing systems, wide format printing capabilities, embossing and paper, film or foil printing. Herman J. Meyering founded the company in 1912 as Genesee Valley Lithographic Company. Hammer Packaging moved to its 90,000-square-foot facility in West Henrietta, N.Y., in April 1999. The company also operates two subsidiaries in Rochester, N.Y., J. MacKenzie, a paper sheeting and converting facility, and New Frontier Packaging, a flexo-graphic packaging printing operation founded in 1992 and 1999, respectively.

Lennox Tech Enterprise Center is a non-profit organization based in West Henrietta, NY, dedicated to helping innovative technology companies launch and grow. They offer a range of services, including startup incubation, manufacturing acceleration, and support for climate tech ventures. With a focus on reducing risk and cost, Lennox Tech Enterprise Center provides funding opportunities, resources, and programming to help entrepreneurs and manufacturers thrive in the Finger Lakes Region. Their impact is evident through the creation of jobs, economic growth, and the success of their diverse portfolio of startups. As the anchor of Rochester's Innovation Zone, Lennox Tech Enterprise Center is a leading resource for startup programming in the region. They provide support without taking equity, making their programs accessible to all. With a commitment to fostering innovation and collaboration, Lennox Tech Enterprise Center plays a vital role in driving the growth and success of the startup community in West Henrietta and beyond.Generated from the website

Adarza Biosystems, located in West Henrietta, NY, specializes in advanced biosensor technology to enhance the understanding of the immune response to various pathogens, including COVID-19. Their innovative ZIVA platform enables the development of both fixed and custom assays, aimed at providing high-definition insights into the body's immune reactions. With a commitment to research and development, Adarza has shifted its focus to the SARS-CoV-2 virus as it prepares for the commercialization of its protein biosensor. The company's efforts highlight its role in the biotech industry, contributing to significant advancements in immune response monitoring and diagnostics. Generated from the website